These buys are by the Big Guns, probably those who bought in awhile ago. They know that the real asset in ZY is the platform they built - extensive scientific knowledge & experience, excellent data capture and analytics, and superb robotics to allow for rapid testing of variants for increased quality & yield. Hyaline was just the first proprietary product, but they've been doing this with various chemicals for years. Yes, Hyaline's difficulties are a problem, but anyone other than day traders knows to hold and, when opportunities like yesterday arise, buy. $8.50 / share was an amazing overreaction. $Zymergen, Inc.(ZY)$
精彩评论